Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Mayor Donna Deegan held a signing ceremony to join Fast-Track Cities, adding Jacksonville to the hundreds of metro areas ...

The Department of Health is warning patients of a former Deer Park dentist to get tested for viral hepatitis and HIV. The dentistry license of Dr. Sandy Montano was revoked earlier this year after a ...

Keywords: HIV, Gene Editing, CRISPR-Cas9, Antiviral Therapy, Genetic Engineering Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which ...

The Guilford County Division of Public Health’s Health Action Group and Clinical Services Section is offering no-cost mpox ...

The trial of dozens of men accused of raping an unconscious woman whose husband repeatedly drugged her over the course of ...

MIT researchers have developed a new HIV vaccination method that generates a strong immune response with just two doses, one ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...